Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2014
01/30/2014US20140031360 Bicyclic compounds as pim inhibitors
01/30/2014US20140031358 Quinazolinediones and their use
01/30/2014US20140031354 Protein Kinase Inhibitors
01/30/2014US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses
01/30/2014US20140031345 Quinazolines as potassium ion channel inhibitors
01/30/2014US20140031331 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
01/30/2014US20140031329 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
01/29/2014EP2688883A1 Novel pyrimidine derivatives
01/29/2014EP2688882A1 Pyrazole compounds as crth2 antagonists
01/29/2014EP2688881A1 New azaspirodecanone compounds as hsl inhibitors
01/29/2014EP2688870A1 Heterocyclic amine derivatives
01/29/2014EP2435435B1 Pyrimidine inhibitors of kinase activity
01/29/2014EP2401269B1 Indole derivatives as crth2 receptor antagonists
01/29/2014EP2394999B1 Aminopyrazine derivative and medicine
01/29/2014EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
01/29/2014CN1849306B Matrix metalloproteinase inhibitors
01/29/2014CN103539818A Bipolar phosphorescent host compound, preparation method and application, as well as electroluminescent device
01/29/2014CN103539786A Benzotriazole imidazoline and derivative and synthesis process and application thereof
01/29/2014CN103539785A 大麻素受体调节剂 Cannabinoid receptor modulators
01/29/2014CN103539784A Heterocyclic benzamide compounds, pharmaceutical compositions as well as application thereof
01/29/2014CN103539751A S-triazine derivatives and application thereof to organic electroluminescence devices
01/29/2014CN103539716A One group of 2-para chlorphenyl-4-substituted methyl-5- trifluoromethyl-3-cyanpyrrole compounds
01/29/2014CN102786514B Novel preparation method of eletriptan
01/29/2014CN102603718B Synthesis method of cediranib
01/29/2014CN102245598B 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
01/29/2014CN101495458B Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors
01/28/2014US8637681 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof
01/28/2014US8637561 Linked diimidazole derivatives
01/28/2014US8637555 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
01/28/2014US8637546 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)
01/28/2014US8637545 Piperidine-2, 6-dione derivatives and their use as tumor necrosis factor inhibitors
01/28/2014US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta
01/28/2014US8637518 Pyridazinone derivatives
01/28/2014US8637498 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
01/28/2014CA2621040C 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
01/28/2014CA2508170C Pyrazine-based tubulin inhibitors
01/23/2014WO2014015291A1 FUSED PYRIMIDINES AS INHIBITORS OF p97 COMPLEX
01/23/2014WO2014015247A1 Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
01/23/2014WO2014015054A1 Beta amino acid derivatives as integrin antagonists
01/23/2014WO2014014962A1 5ht3 receptor antagonists
01/23/2014WO2014014951A1 5-ht3 receptor antagonists
01/23/2014WO2014014314A1 Hetrocyclic derivative having dual inhibitory activity
01/23/2014WO2014014310A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
01/23/2014WO2014014050A1 1-(cycloalkyl-carbonyl)proline derivative
01/23/2014WO2014013115A1 Beta-lactam apaf-1-inhibitor compounds
01/23/2014WO2014012859A1 Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as medicament and the preparation thereof
01/23/2014WO2014012563A1 Compounds for enhancing the cognitive function
01/23/2014WO2014012511A1 N-(3-heteroarylaryl)-4-arylarylcarboxamtdes and analogs as hedgehog pathway inhibitors and use thereof
01/23/2014WO2014002109A4 Substituted tetrazole compounds and process thereof
01/23/2014WO2013151597A3 (1,2,3-triazolyl) sulfonyl derivatives
01/23/2014US20140024838 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1
01/23/2014US20140024835 Dual-acting antihypertensive agents
01/23/2014US20140024680 Insecticidal Arylpyrrolines
01/23/2014US20140024661 Fused pyrimidines and substituted quinazolines as inhibitors of p97
01/23/2014US20140024659 N-substituted hetero-bicyclic compounds and derivatives for combating animal pests
01/23/2014US20140024657 Small molecule inhibitors of necroptosis
01/23/2014US20140024648 New pyridazinone and pyridone compounds
01/23/2014US20140024647 Aromatic heterocyclic derivative having trpv4-inhibiting activity
01/23/2014US20140024628 Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof
01/23/2014US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof
01/22/2014EP2687524A1 Azole derivative
01/22/2014EP2687518A1 Nitrogen-containing saturated heterocyclic compound
01/22/2014EP2687516A1 Inhibitors of C-FMS Kinase
01/22/2014EP2686317A2 Raf kinase inhibitors
01/22/2014EP2686314A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor
01/22/2014EP2686313A1 Benz imidazole derivatives as inhibitors of glutaminyl cyclase
01/22/2014EP2686300A1 New azaspirodecanone compounds
01/22/2014EP2685828A1 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists
01/22/2014EP2685824A1 Indole derivatives useful as ccr2 antagonists
01/22/2014CN103534256A Macrocyclic hepatitis c serine protease inhibitors
01/22/2014CN103534251A Novel compounds for organic electronic material and organic electroluminescent device using the same
01/22/2014CN103534239A Substituted indazole derivatives active as kinase inhibitors
01/22/2014CN103524500A Preparation method of benzoxazine containing maleimide bisphenol A-type structure
01/22/2014CN103524497A Bipolar phosphorescent host compounds, preparation method, application and electroluminescent device
01/22/2014CN103524496A Purifying method of candesartan cilexetil
01/22/2014CN103524495A Process for preparing 2, 3-disubstituted indoles
01/22/2014CN103524436A 1-[(3-alkoxy-6-substituted-quinoxalin-2-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
01/22/2014CN103524419A Group of 3-trifluoromethyl pyrazole compounds
01/22/2014CN103524418A 3-methyl pyrazol compounds
01/22/2014CN103524417A 3-methyl-4-formyl pyrazol compounds
01/22/2014CN103524399A Organic compound and electroluminescent device using same
01/22/2014CN103524397A 3-sulfimidyl indole compound and preparation method thereof
01/22/2014CN103524396A Diamidine derivative containing indole ring as well as preparation and method of derivative
01/22/2014CN103524392A Azetidines as mek inhibitors for the treatment of proliferative diseases
01/22/2014CN102753540B A4ss2 neuronal nicotinic acetylcholine receptor ligands
01/22/2014CN102491972B Carbazole derivative, preparation method thereof, and application of carbazole derivative serving as anticancer drug
01/22/2014CN101772487B Thyroid compounds
01/21/2014USRE44721 Method of making monoammonium salt of bis-(1(2)H-tetrazol-5-yl)-amine
01/21/2014US8633313 Heterocyclic compounds and their uses
01/21/2014US8633239 Process for the preparation of eletriptan
01/21/2014US8633231 Substituted imidazolones, compositions containing such compounds and methods of use
01/21/2014US8633222 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
01/21/2014US8633210 Triazole compounds useful as protein kinase inhibitors
01/21/2014US8633208 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands
01/21/2014CA2605050C Histone deacetylase inhibitors
01/21/2014CA2586106C Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases
01/16/2014WO2014012074A2 No-releasing nonoate (nitrogen-bound) sulfonamide-linked-coxib anti-cancer agents
01/16/2014WO2014011973A2 Quinazolinone-based oncogenic-ras-selective lethal compounds and their use
01/16/2014WO2014011491A1 Carbazole substituted triazole, triazine, and tetrazine ambipolar host materials and devices
01/16/2014WO2014011483A1 Oxadiazole and triazole meta-linked n-phenyl carbazole ambipolar host materials
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 626